Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

9 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The Determining Effective Testing in Emergency Departments and Care Coordination on Treatment Outcomes (DETECT) for Hepatitis C (Hep C) Linkage-to-Care Trial: rationale and design of an emergency department-based randomized clinical trial of linkage-to-care strategies for hepatitis C.
Rowan SE, Haukoos J, Kamis KF, Hopkins E, Gravitz S, Lyle C, Al-Tayyib AA, Gardner EM, Galbraith JW, Hsieh YH, Lyons MS, Rothman RE, White DAE, Morgan JR, Linas BP, Sabel AL, Wyles DL; DETECT Hep C Trials Investigators. Rowan SE, et al. Among authors: kamis kf. Trials. 2023 Jan 27;24(1):63. doi: 10.1186/s13063-022-07018-w. Trials. 2023. PMID: 36707909 Free PMC article. Clinical Trial.
The Determining Effective Testing in Emergency Departments and Care Coordination on Treatment Outcomes (DETECT) for Hepatitis C (Hep C) Screening Trial: rationale and design of a multi-center pragmatic randomized clinical trial of hepatitis C screening in emergency departments.
Haukoos JS, Rowan SE, Galbraith JW, Rothman RE, Hsieh YH, Hopkins E, Houk RA, Toerper MF, Kamis KF, Morgan JR, Linas BP, Al-Tayyib AA, Gardner EM, Lyons MS, Sabel AL, White DAE, Wyles DL; DETECT Hep C Trials Investigators. Haukoos JS, et al. Among authors: kamis kf. Trials. 2022 Apr 25;23(1):354. doi: 10.1186/s13063-022-06265-1. Trials. 2022. PMID: 35468807 Free PMC article. Clinical Trial.
HIV and COVID-19: review of clinical course and outcomes.
Barbera LK, Kamis KF, Rowan SE, Davis AJ, Shehata S, Carlson JJ, Johnson SC, Erlandson KM. Barbera LK, et al. Among authors: kamis kf. HIV Res Clin Pract. 2021 Aug;22(4):102-118. doi: 10.1080/25787489.2021.1975608. Epub 2021 Sep 12. HIV Res Clin Pract. 2021. PMID: 34514963 Free PMC article.
Risk Factors for Hospitalization in People With HIV and COVID-19.
Kamis KF, Barbera L, Abdo M, Rowan SE, Hussain C, Gardner EM, Johnson SC, MaWhinney S, Davis AJ, Carlson J, Kozacka KA, Erlandson KM. Kamis KF, et al. J Acquir Immune Defic Syndr. 2021 Nov 1;88(3):e22. doi: 10.1097/QAI.0000000000002780. J Acquir Immune Defic Syndr. 2021. PMID: 34334740 Free PMC article. No abstract available.
Same-Day HIV Pre-Exposure Prophylaxis (PrEP) Initiation During Drop-in Sexually Transmitted Diseases Clinic Appointments Is a Highly Acceptable, Feasible, and Safe Model that Engages Individuals at Risk for HIV into PrEP Care.
Kamis KF, Marx GE, Scott KA, Gardner EM, Wendel KA, Scott ML, Montgomery AE, Rowan SE. Kamis KF, et al. Open Forum Infect Dis. 2019 Jun 27;6(7):ofz310. doi: 10.1093/ofid/ofz310. eCollection 2019 Jul. Open Forum Infect Dis. 2019. PMID: 31341933 Free PMC article.